A genetic medicine company that build data platforms using synthetic biology, artificial intelligence and genetic medicine for the development of medical therapies.
Project Saturn is the name of Deep Genomics artificially intelligent drug prediction and design platform. The project is analyzing over 69 billion oligonucleotides against 1 million gene targets and narrowing down their results to produce 1000 potential new compounds that will work to have the predicted biological affect. The platform is able to continuously improve its predictions in a closed loop based on its failures and successes in reference to human cells. The system is designed to predict what affect an antisense oligonucleotide compound (AGO) on human cells, taking into account individual genotype and multiple biological mechanisms.